Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0002871 (anemia)
 52,094 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Centrineurogenic shock lung following acute hemorrhage was prevented by Dilantin (DPH) given preshock. Nineteen anemia (Hct = 30 +/- 5%) dogs were divided into five groups: one control (no anesthesia, no shock); one of three with 4 hours of anesthesia alone; and of 15 dogs with hemorrhagic shock, eight were without DPH, two with preshock DPH, and five received DPH 15 min after shock was established. Shock animals were rapidly bled to 40 mm Hg which was maintained for 2 hours, and all shed blood was reinfused. One hour later, all animals were sacrificed, the lungs fixed with formalin instilled at 15 cm H2O intratracheal pressure, the trachea cross-clamped, the lungs excised, photographed, and sent for gross and histopathologic study. Shock animals without DPH had grossly hemorrhagic lungs with diffuse interstitial and alveolar congestion, hemorrhage, and edema. Neither of the DPH-treated groups developed gross changes and showed minimal to no histopathology. Dilantin given early in established hemorrhagic shock prevents shock lung.
 ...
PMID:Suppression of centrineurogenic shock lung by Dilantin (DPH) administered early in established hemorrhagic shock. 727 41

Dilantin hypersensitivity syndrome is characterized by fever, rash, lymphadenopathy, facial edema, and hepatitis. Anemia, pharyngitis, diarrhea, and nephritis may also be present. The eruption may present as the classic erythematous follicular papules and pustules; or it may be pleomorphic, presenting as a morbilliform eruption, erythroderma, or toxic epidermal necrolysis. Early recognition and discontinuation of the medication are necessary to prevent a potentially fatal outcome. A case is presented and the literature reviewed.
 ...
PMID:Dilantin hypersensitivity reaction. 872 70